Explore All Access
Check if your research matches the topics covered in Nature Reviews Clinical Oncology?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Nature Reviews Clinical Oncology : Impact Factor & More
eISSN: 1759-4782pISSN: 1759-4774
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Nature Reviews Clinical Oncology Key Metrics
CiteScore 
63.5
Impact Factor
>= 25
SNIP
7.95
Topics Covered on Nature Reviews Clinical Oncology
Nature Reviews Clinical Oncology Journal Specifications
| Overview | |
| Publisher | NATURE PORTFOLIO |
| Language | English |
| Frequency | Monthly |
| General Details |
View less
Planning to publish in Nature Reviews Clinical Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Nature Reviews Clinical Oncology
Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer.
- 13 May 2025
- Nature reviews. Clinical oncology
Promising results with zongertinib in advanced-stage HER2-mutant NSCLC.
- 13 May 2025
- Nature reviews. Clinical oncology
Next-generation KRAS-G12C inhibitor D3S-001 shows promise.
- 9 May 2025
- Nature reviews. Clinical oncology
Extended neoadjuvant dostarlimab provides durable benefit in resectable dMMR solid tumours.
- 7 May 2025
- Nature reviews. Clinical oncology
Improving outcomes of patients with pancreatic cancer.
- 6 May 2025
- Nature reviews. Clinical oncology
The evolving immuno-angiogenic paradigm in NSCLC: lessons from ivonescimab.
- 6 May 2025
- Nature reviews. Clinical oncology
Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer.
- 13 May 2025
- Nature reviews. Clinical oncology
Promising results with zongertinib in advanced-stage HER2-mutant NSCLC.
- 13 May 2025
- Nature reviews. Clinical oncology
Next-generation KRAS-G12C inhibitor D3S-001 shows promise.
- 9 May 2025
- Nature reviews. Clinical oncology
Extended neoadjuvant dostarlimab provides durable benefit in resectable dMMR solid tumours.
- 7 May 2025
- Nature reviews. Clinical oncology
Improving outcomes of patients with pancreatic cancer.
- 6 May 2025
- Nature reviews. Clinical oncology
The evolving immuno-angiogenic paradigm in NSCLC: lessons from ivonescimab.
- 6 May 2025
- Nature reviews. Clinical oncology
Compare Similar Journals with Nature Reviews Clinical Oncology
Select Journals to Compare with Nature Reviews Clinical Oncology
Total journals - 10
You can select up to 3 Journals at a time
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Cancers
Publisher: MDPI
Annals of Oncology
Publisher: ELSEVIER
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Clinical Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Journal for ImmunoTherapy of Cancer
Publisher: BMJ PUBLISHING GROUP
European Journal of Cancer
Publisher: ELSEVIER SCI LTD
International Journal of Molecular Sciences
Publisher: MDPI
Frontiers in Immunology
Publisher: FRONTIERS MEDIA SA
0 Journals Selected to compare with
Nature Reviews Clinical Oncology
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
